Go Back

Company or ticker...

Sarepta Therapeutics

Sarepta develops genetic and RNA-based treatments for rare diseases, particularly Duchenne muscular dystrophy.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

SRPT

1.8B

0.9

n/a

-23.77%

Key Facts

M. Cap

PS

PE

YTD

1.8B

0.9

n/a

-23.77%

10MA

20MA

50MA

200MA

$SRPT

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now